Company News

Share this article:

Roche sued Mylan to prevent the latter from marketing a generic version of its Xeloda breast cancer treatment. According to a Bloomberg report, Xeloda pulled in over $1 billion in sales last year. The drug is also indicated as a treatment for colon cancer following surgery.

 

Spectrum Science Communications, a Washington DC-based health and science communications firm, is refining its name and rebranding itself as Spectrum. The company opened an office in New York, and has invested resources in digital media, consumer marketing and health policy, and added a research partner.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.